NYSE: HAE
Haemonetics Corp Stock Ownership - Who owns Haemonetics?

Insider buying vs selling

Have Haemonetics Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Farris Maryanne MaunsellVP Chief Accounting Officer2026-06-05259$71.28
$18.46kSell
Laurie A. MillerSVP Human Resources2026-06-05313$71.28
$22.31kSell
James DareccaEVP Chief Financial Officer2026-05-152,505$56.29
$141.01kSell
Roy GalvinEVP Chief Commercial Officer2026-05-15879$56.29
$49.48kSell
Michelle L. BasilEVP and General Counsel2026-05-152,913$56.29
$163.97kSell
Frank ChanEVP Chief Operating Officer2026-05-15546$56.29
$30.73kSell
Farris Maryanne MaunsellVP Chief Accounting Officer2026-05-15197$56.29
$11.09kSell
Laurie A. MillerSVP Human Resources2026-05-15948$56.29
$53.36kSell
Christopher SimonPresident CEO2026-05-159,681$56.29
$544.94kSell
James DareccaEVP Chief Financial Officer2026-05-01655$59.26
$38.82kSell

1 of 2

HAE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when HAE insiders and whales buy or sell their stock.

HAE Shareholders

What type of owners hold Haemonetics Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Christopher Simon0.98%444,704$47.28MInsider
Brian Concannon0.32%147,040$15.63MInsider
Michelle L. Basil0.15%68,829$7.32MInsider
Christopher J. Lindop0.12%56,743$6.03MInsider
James Darecca0.12%54,444$5.79MInsider
Curated Wealth Partners LLC0.11%50,000$5.32MInstitution
Ronald G. Gelbman0.11%48,384$5.14MInsider
Sandra Jesse0.11%48,166$5.12MInsider
Laurie A. Miller0.09%40,987$4.36MInsider
Roy Galvin0.09%39,882$4.24MInsider

1 of 3

HAE vs Medical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
HAE0.11%3.84%Net Selling
MMSI0.10%5.84%Net SellingNet Selling
TFX0.11%3.43%Net Selling
NVST0.12%66.21%Net SellingNet Selling
PLSE0.02%78.74%Net BuyingNet Buying

Haemonetics Stock Ownership FAQ

Who owns Haemonetics?

Haemonetics (NYSE: HAE) is owned by 0.11% institutional shareholders, 3.84% Haemonetics insiders, and 96.05% retail investors. Christopher Simon is the largest individual Haemonetics shareholder, owning 444,704.00 shares representing 0.98% of the company. Christopher Simon's Haemonetics shares are currently valued at $47.23M.

If you're new to stock investing, here's how to buy Haemonetics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.